Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peri-articular Ropivacaine + Morphine vs Ropivacaine Alone After ACL Reconstruction
KCT0003572Phase 4Recruiting
- Sponsor
- Daewon Pharm
- Start
- Jan 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine, morphine in anterior cruciate ligament injury, sponsored by Daewon Pharm. Started Jan 2019; status: recruiting.
02
Drugs
ropivacainemorphine
03
Conditions
anterior cruciate ligament injury
Beyond the preview
Go deeper on KCT0003572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003572.